(Q52244675)

28 April 2018

title

Reduced test time by early identification of patients requiring atropine during dobutamine stress echocardiography. (English)

1 reference

28 April 2018

1 reference

0 references

Lewandowski TJ

1

1 reference

28 April 2018

Armstrong WF

series ordinal

2

1 reference

28 April 2018

Bach DS

series ordinal

3

1 reference

28 April 2018

publication date

1 March 1998

1 reference

28 April 2018

Journal of the American Society of Echocardiography

published in

1 reference

28 April 2018

volume

11

1 reference

28 April 2018

issue

3

1 reference

28 April 2018

page(s)

236-242

1 reference

28 April 2018

Accuracy of dobutamine stress echocardiography in detecting coronary artery disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Dobutamine-atropine stress echocardiography for assessment of perioperative and late cardiac risk in patients undergoing major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Dobutamine stress echocardiography before and after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test. Hemodynamic characteristics, safety, and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

Effects of prolonging peak dobutamine dose during stress echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2898%2970085-9

7 January 2021

10.1016/S0894-7317(98)70085-9

Identifiers

DOI

1 reference

28 April 2018

PubMed ID

9560747

1 reference

28 April 2018